In the present study, we investigated whether the degree of oxidative stress measured by serum HO-1 levels at the diagnosis could be useful for predicting prognosis and these levels could decrease during the clinical courses among patients with ARDS and AE-ILDs. This evidence concerns the gene HMOX1 and acute respiratory distress syndrome.